TrialThe Journal of clinical endocrinology and metabolism2014

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Benjamin Z Leder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.